@FierceMedDev: Infraredx snags $25M as it sets sights on Japan. News | Follow @FierceMedDev
@DamianFierce: Bard settled another vaginal mesh lawsuit. That leaves about 7,999 to go. News | Follow @DamianFierce
@MarkHFierce: Why does Medtronic CEO Omar Ishrak tweet? Editor's corner | Follow @MarkHFierce
@MichaelGFierce: ICYMI... Study: Insulin pumps improve glycemic control in children with diabetes. Article | Follow @MichaelGFierce
> Life Technologies ($LIFE) has successfully convinced its shareholders to accept Thermo Fisher's ($TMO) $13.6 billion takeover bid. News
> AtriCure ($ATRC) has expanded its distribution deal with Japan's Century Medical, giving local Century rights to more of AtriCutre's cardiac devices. More
> Navidea Biopharmaceuticals ($NAVB) secured the FDA's blessing to switch up the endpoints of its Phase III trial of NAV5001, an imaging agent designed to identify Parkinson's disease. Item
> California's Eclipse Breast Health is going the crowdfunding route to develop its hand-held imaging device, seeking $650,000 on Indiegogo. Story
> The FDA has embraced 3-D printing technology, using it in research and evaluation of medical devices. Blog post
> Imaging company VirtualScopics ($VSCP) will pursue a 1-for-10 reverse stock split. Item
> SomaLogic, a company focused, in part, on clinical diagnostics, has raised $10 million in equity financing. Item (reg. req.)
> Rinovum Women's Health gained a CE mark for a cervical-cap conception device designed to assist couples struggling with fertility. Story
Biotech News
@FierceBiotech: Popular yesterday: Incyte shares soar on positive pancreatic cancer trial data for Jakafi. Article | Follow @FierceBiotech
@JohnCFierce: FYI, we're adding a weekly diagnostics report to go along with our fast-growing med devices group of pubs. End of the month. Look for it. | Follow @JohnCFierce
@EmilyMFierce: Sodium 'switch' could provide target to treat brain disorders. Item | Follow @EmilyMFierce
> Analyst: Time to wrap up Amgen's $9.5B Onyx buyout. Story
> Regado misses IPO fiesta, limps into public spotlight with $43M raise. Article
> U.S./China biotech hybrid lands $25M to back global R&D strategy. Report
Pharma News
@FiercePharma: China's pharma probe intensifies with British consultant's arrest. ICYMI yesterday | Follow @FiercePharma
@CarlyHFierce: Check out Eli Lilly's statement on the latest bribery allegations in China. Article | Follow @CarlyHFierce
> Teva chairman defends CEO Levin from fed-up analysts. More
> Amid Purdue criticism, CVS cuts opioid access for 'risky' prescribers. Story
> Onyx hands bidders new Kyprolis data to smooth path to $9.5B deal. Report
Vaccines News
> Sanofi delays return of vaccines after testing 'anomaly.' More
> GSK-backed study links flu vaccine to lower risk of heart attack. Report
> Improved vaccines mean flu immunization can start earlier. Story
> Vaccine refusers to miss out on tax benefits under Australian plan. Article
> India to investigate safety of pentavalent vaccines. More
Pharma Manufacturing News
@EricPFierce: Regeneron will turn an empty Dell computer plant in Ireland into its second manufacturing plant. Article | Follow @EricPFierce
> Dr. Reddy's recall affects Walmart, Walgreens, Supervalu. Item
> Doxycycline shortage shot in the arm for Hikma profits. More
> FDA not alone in acting on compounding pharmacies. Article
> Fresenius Kabi expands manufacturing in Indonesia with JV. Story